Recherche par structure

(+)-Quinidine, Thermo Scientific Chemicals

Thermo Scientific Chemicals

(+)-Quinidine, Thermo Scientific Chemicals

Name: (+)-Quinidine, Thermo Scientific Chemicals
SKU: A12559.06
Price: 49.65 EUR

CAS: 56-54-2 | C20H24N2O2 | 324.42 g/mol

Modifier l'affichage

Quantité:

1 g

5 g

25 g

Essayez l'application web chem dex^TM

Référence A12559.06

également connu sous le numéro A12559-06

Prix (EUR)

49,65

Online Exclusive

55,40

Économisez 5,75 (10%)

Each

Quantité:

5 g

Grand volume ou format personnalisé

Prix (EUR)

49,65

Online Exclusive

55,40

Économisez 5,75 (10%)

Each

Identifiants chimiques

CAS56-54-2

IUPAC Name(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol

Molecular FormulaC20H24N2O2

InChI KeyLOUPRKONTZGTKE-LHHVKLHASA-N

SMILESCOC1=CC=C2N=CC=C([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)C2=C1

Spécifications Specification Sheet

Fiche de spécifications

FormPowder or crystalline powder

Identification (FTIR)Conforms

Optical Rotation+250° to +270° (c=1 in ethanol)

Appearance (Color)White to cream to yellow to brown

Assay (Non-aqueous acid-base Titration)≥94.0 to ≤106.0% (quinidine + dihydroquinidine)

(+)-Quinidine is used to treat or prevent many types of irregular heartbeats (heart arrhythmias such as atrial fibrillation). It may also be used to treat malaria.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubilité
Soluble dans le méthanol, le chloroforme, l’alcool (1 g/36 ml), le benzène et le DMSO(100 mM). Légèrement soluble dans l’éther et l’éther de pétrole. Insoluble dans l’eau.

Remarques
Sensible à la lumière. Incompatible avec les agents oxydants.

RUO – Research Use Only

Références générales :

Dan M.Roden, M.D. ; Raymond L.Woosley, M.D., Ph.D. ; R.Kirby Primm, M.D. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. American Heart Journal. 1986, 111, (6)1088-1093
Alain Borgeat, MD ; Jean-Jacques Goy, MD ; Raymond Maendly, MD ; Urs Kaufmann, MD ; MilanGrbic, MD ; Ueli Sigwart, MD. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology. 1986, 58, (6)496-498